For medicinal products authorised under Regulation (EC) No 726/2004, the refusal of the European Medicines Agency to accept a variation should terminate the procedure. Likewise, a Commission decision should not be required regarding variations that do not amend the terms of the decision granting the marketing authorisation.
Recital 8, Commission Regulation (EU) No 712/2012 of 3 August 2012 amending Regulation (EC) No 1234…
In forcesince 3 Aug 2012